期刊文献+

人结直肠癌微小核糖核酸的差异表达及其临床意义 被引量:3

Clinical significance of aberrant microRNAs expression in human colorectal cancer
下载PDF
导出
摘要 目的:研究人结直肠癌、腺瘤和癌旁正常组织中微小核糖核酸(microRNAs,miRNAs)的差异表达谱,并初步探讨其临床意义.方法:选取2008-01/07苏州大学附属第一医院和泰州市人民医院结直肠癌、对应癌旁正常组织以及结直肠腺瘤标本,提取组织总RNA,采用illumina microRNA芯片技术检测3种不同类型组织中miRNAs的表达,采用实时定量PCR技术对芯片检测结果进行验证.将结直肠癌组织中异常表达的miRNAs与结直肠癌患者的临床病理资料进行分析.结果:3种不同类型结直肠组织中miRNAs表达有明显差异,结直肠癌与癌旁正常组织相比,有65个miRNAs表达异常(P<0.001),其中35个上调,30个下调,而腺瘤与正常结直肠组织相比,有55个miRNAs表达差异(P<0.001),其中上调29个,下调26个.有25个miRNAs相对于正常组织同时在结直肠癌和腺瘤中异常表达,其中高表达12个,低表达有13个.与腺瘤相比,结直肠癌中有25个miRNAs表达异常(P<0.01),其中13个上调,12个下调.进一步定量PCR验证结果显示与正常结直肠黏膜组织相比,在癌组织中miR-552,miR-142-3p上调(2.97±2.72vs0.98±0.48;3.64±3.41vs1.31±0.61,均P<0.05),miR-139-3p和miR-133b下调(0.10±0.26vs0.82±0.70,0.81±0.67vs1.71±1.29,均P<0.05),与芯片结果相吻合.miR-552和miR-139-3p与结直肠癌患者年龄、性别、组织学、肿瘤大小和浸润深度无关(P>0.05),而miR-552与TNM分期、淋巴结和肝转移相关(P<0.05),miR-139-3p与TNM分期和肝转移相关(P<0.05),miR-142-3p除与组织学有关外,与其他临床病理参数无关,miR-133b与年龄相关,而与其他临床病理参数无关.结论:miRNAs参与了结直肠的癌变过程,特异的miRNAs的表达可能成为结直肠癌潜在的早期诊断和治疗新靶点. AIM:To investigate the expression profile of microRNAs(miRNAs) in human colorectal cancer and to analyze the clinical significance of aber-rant miRNA expression. METHODS:The expression of miRNAs in colorectal cancer specimens,matched normal mucosal specimens,and adenoma specimens was detected by miRNA microarray.The differential expression of some miRNAs was verified by real-time RT-PCR.The correlation of aberrant miRNA expression with clinical and biopathologic features in colorectal cancer,such as age,gender,tumor size,lymph node and distance metastasis,clinical stage as well as histological grade,was analyzed. RESULTS:Microarray analysis revealed many miRNAs that could clearly differentiate colorectal cancer from adenoma and normal tissue. Thirty-five significantly up-regulated miRNAs and 30 down-regulated miRNAs were identified in carcinoma in comparison to normal tissue(P 〈0.001) ,whereas 25 aberrantly expressed miRNAs were identified in cancer in comparison to adenoma(P〈0.01) .In addition,55 miRNAs could distinguish adenoma from normal colorectal mucosa(P〈0.001) .Twelve up-regulated miRNAs and 13 down-regulated ones were simultaneously aberrantly expressed in cancer and adenoma.Quantitative RT-PCR analysis showed that miR-552 and miR-142-3p were significantly up-regulated(2.97±2.72 vs 0.98±0.48,P〈0.05;3.64±3.41 vs 1.31±0.61,P〈0.05) and miR-139-3p and miR-133b were down-regulated in cancer tissue compared with normal mucosa(0.10±0.26 vs 0.82±0.70,P〈0.05;0.81±0.67 vs 1.71±1.29,P〈0.05) ,which is consistent with the microarray results.Aberrant miR-552 expression was correlated with TNM stage and lymph node and distance metastasis(all P〈0.05) ,but not with age,gender,tumor size or histological grade.Aberrant miR-139-3P expression was correlated with TNM stage and distance metastasis,while differential expression of miR-142-3p was correlated with histological grade. CONCLUSION:Differential miRNA expression could help distinguish malignant tissue from adenoma and normal mucosa,suggesting that aberrant miRNA expression might be involvedin colorectal tumorigenesis.Differentially expressed miRNAs might be used as early diagnosis markers or therapeutic targets for human colorectal cancer.
出处 《世界华人消化杂志》 CAS 北大核心 2010年第30期3187-3194,共8页 World Chinese Journal of Digestology
基金 江苏省333工程科研基金资助项目 江苏省卫生厅科技基金资助项目 No.H200959 苏州市科技局基金资助项目 No.YJS0915~~
关键词 结直肠癌 微小核糖核酸芯片 微阵列 实时定量聚合酶链式反应 Colorectal cancer microRNAs chip Microarray Real-time polymerase chain reaction
  • 相关文献

参考文献31

  • 1Derks S,Postma C,Moerkerk PT,van den Bosch SM,Carvalho B,Hermsen MA,Giaretti W,Herman JG,Weijenberg MP,de Bru?ne AP,Meijer GA,van Engeland M.Promoter methylation precedes chromosomal alterations in colorectal cancer development.Cell Oncol 2006;28:247-257
  • 2Hermsen M,Postma C,Baak J,Weiss M,Rapallo A,Sciutto A,Roemen G,Arends JW,Williams R,Giaretti W,De Goeij A,Meijer G.Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability.Gastroenterology 2002;123:1109-1119.
  • 3Lee Y,Ahn C,Han J,Choi H,Kim J,Yim J,Lee J,Provost P,R?dmark O,Kim S,Kim VN.The nuclear RNase III Drosha initiates microRNA processing.Nature 2003;425:415-419.
  • 4Lund E,Güttinger S,Calado A,Dahlberg JE,Kutay U.Nuclear export of microRNA precursors.Science 2004;303:95-98.
  • 5Lai EC.Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation.Nat Genet 2002;30:363-364.
  • 6Liu J,Rivas FV,Wohlschlegel J,Yates JR 3rd,Parker R,Hannon GJ.A role for the P-body component GW182 in microRNA function.Nat Cell Biol 2005;7:1261-1266.
  • 7Esquela-Kerscher A,Slack FJ.Oncomirs - microRNAs with a role in cancer.Nat Rev Cancer 2006;6:259-269.
  • 8Calin GA,Sevignani C,Dumitru CD,Hyslop T,Noch E,Yendamuri S,Shimizu M,Rattan S,Bullrich F,Negrini M,Croce CM.Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.Proc Natl Acad Sci U S A 2004;101:2999-3004.
  • 9Cho WC.OncomiRs:the discovery and progress of microRNAs in cancers.Mol Cancer 2007;6:60.
  • 10Hammond SM.MicroRNAs as oncogenes.Curr Opin Genet Dev 2006;16:4-9.

同被引文献27

  • 1Zhu, Yi-Min,Zhong, Zheng-Xiang,Liu, Zhi-Ming.Relationship between let-7a and gastric mucosa cancerization and its significance[J].World Journal of Gastroenterology,2010,16(26):3325-3329. 被引量:17
  • 2Maria Di Lena,Elisabetta Travaglio,Donato F Altomare.New strategies for colorectal cancer screening[J].World Journal of Gastroenterology,2013,19(12):1855-1860. 被引量:12
  • 3Zhang BG,Li JF,Yu BQ. MicroRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN[J].Oncology Reports,2012,(04):1019-1026.
  • 4Ren Y,Zhou X,Mei M. MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229(PTEN-wild type) to taxol[J].BMC Cancer,2010.27.
  • 5Schetter AJ,Leung SY,Sohn JJ. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colonadenocarcinoma[J].Journal of the American Medical Association,2008,(04):425-436.
  • 6Yamamichi N,Shimomura R,Inada K. Locked nucleic acid in situ hybridization analysis of miR-21 expressionduring colorectal cancer development[J].Clinical Cancer Research,2009,(12):4009-4016.
  • 7Mueller S,Phillips J,Onar-Thomas A. PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomasand influence on clinical outcome[J].Journal of Neuro-Oncology,2012,(09):1146-1152.
  • 8White MJ,Schoenwaelder SM,Josefsson EC. Caspase-9mediates the apoptotic death of megakaryocytes and platelets,but is dispensable for their generation and function[J].Blood,2012,(18):4283-4290.
  • 9王迎昕,张小燕,张宝峰,张可浩,方静,胡莺,翟宁,陈锡美,郜恒骏.无淋巴结转移结肠癌微小核糖核酸表达谱的初步研究[J].中华消化杂志,2009,29(2):114-117. 被引量:2
  • 10梁旭东,杜焕社,史晓锋.Survivin、PTEN在胃癌中的表达及临床意义[J].中国医师杂志,2009,11(7):901-903. 被引量:4

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部